Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 139

1.

In silico design of a triple-negative breast cancer vaccine by targeting cancer testis antigens.

Parvizpour S, Razmara J, Pourseif MM, Omidi Y.

Bioimpacts. 2019;9(1):45-56. doi: 10.15171/bi.2019.06. Epub 2018 Jul 2.

PMID:
30788259
2.

Dual thermo-and pH-sensitive injectable hydrogels of chitosan/(poly(N-isopropylacrylamide-co-itaconic acid)) for doxorubicin delivery in breast cancer.

Fathi M, Alami-Milani M, Geranmayeh MH, Barar J, Erfan-Niya H, Omidi Y.

Int J Biol Macromol. 2019 Jan 24. pii: S0141-8130(18)34805-0. doi: 10.1016/j.ijbiomac.2019.01.122. [Epub ahead of print]

PMID:
30685304
3.

Phage antibody library screening for the selection of novel high-affinity human single-chain variable fragment against gastrin receptor: an in silico and in vitro study.

Jalilzadeh-Razin S, Mantegi M, Tohidkia MR, Pazhang Y, Pourseif MM, Barar J, Omidi Y.

Daru. 2019 Jan 3. doi: 10.1007/s40199-018-0233-1. [Epub ahead of print]

4.

Microfluidic paper-based analytical devices (µPADs) for fast and ultrasensitive sensing of biomarkers and monitoring of diseases.

Abdollahi-Aghdam A, Majidi MR, Omidi Y.

Bioimpacts. 2018;8(4):237-240. doi: 10.15171/bi.2018.26. Epub 2018 Jul 2.

5.

AS1411 aptamer-decorated cisplatin-loaded poly(lactic-co-glycolic acid) nanoparticles for targeted therapy of miR-21-inhibited ovarian cancer cells.

Vandghanooni S, Eskandani M, Barar J, Omidi Y.

Nanomedicine (Lond). 2018 Nov;13(21):2729-2758. doi: 10.2217/nnm-2018-0205. Epub 2018 Nov 5.

PMID:
30394201
6.

Ultra-sensitive detection by metal nanoparticles-mediated enhanced SPR biosensors.

Fathi F, Rashidi MR, Omidi Y.

Talanta. 2019 Jan 15;192:118-127. doi: 10.1016/j.talanta.2018.09.023. Epub 2018 Sep 11. Review.

PMID:
30348366
7.

Astaxanthin-Loaded Nanostructured Lipid Carriers for Preservation of Antioxidant Activity.

Rodriguez-Ruiz V, Salatti-Dorado JÁ, Barzegari A, Nicolas-Boluda A, Houaoui A, Caballo C, Caballero-Casero N, Sicilia D, Bastias Venegas J, Pauthe E, Omidi Y, Letourneur D, Rubio S, Gueguen V, Pavon-Djavid G.

Molecules. 2018 Oct 11;23(10). pii: E2601. doi: 10.3390/molecules23102601.

8.

Isolation and molecular identification of Lactobacillus with probiotic potential from abomasums driven rennet.

Maleki Kakelar H, Barzegari A, Hanifian S, Barar J, Omidi Y.

Food Chem. 2019 Jan 30;272:709-714. doi: 10.1016/j.foodchem.2018.08.081. Epub 2018 Aug 20.

PMID:
30309602
9.

Electrochemical immunosensor based on chitosan-gold nanoparticle/carbon nanotube as a platform and lactate oxidase as a label for detection of CA125 oncomarker.

Samadi Pakchin P, Ghanbari H, Saber R, Omidi Y.

Biosens Bioelectron. 2018 Dec 30;122:68-74. doi: 10.1016/j.bios.2018.09.016. Epub 2018 Sep 5.

PMID:
30243046
10.

A highly sensitive and reliable detection of CA15-3 in patient plasma with electrochemical biosensor labeled with magnetic beads.

Akbari Nakhjavani S, Khalilzadeh B, Samadi Pakchin P, Saber R, Ghahremani MH, Omidi Y.

Biosens Bioelectron. 2018 Dec 30;122:8-15. doi: 10.1016/j.bios.2018.08.047. Epub 2018 Aug 23.

PMID:
30236808
11.

Breast cancer vaccination comes to age: impacts of bioinformatics.

Parvizpour S, Razmara J, Omidi Y.

Bioimpacts. 2018;8(3):223-235. doi: 10.15171/bi.2018.25. Epub 2018 Apr 18. Review.

12.

Stable transformation of Spirulina (Arthrospira) platensis: a promising microalga for production of edible vaccines.

Dehghani J, Adibkia K, Movafeghi A, Barzegari A, Pourseif MM, Maleki Kakelar H, Golchin A, Omidi Y.

Appl Microbiol Biotechnol. 2018 Nov;102(21):9267-9278. doi: 10.1007/s00253-018-9296-7. Epub 2018 Aug 29.

PMID:
30159589
13.

Pathogenicity of Helicobacter pylori in cancer development and impacts of vaccination.

Maleki Kakelar H, Barzegari A, Dehghani J, Hanifian S, Saeedi N, Barar J, Omidi Y.

Gastric Cancer. 2019 Jan;22(1):23-36. doi: 10.1007/s10120-018-0867-1. Epub 2018 Aug 25. Review.

PMID:
30145749
14.

Bispecific therapeutic aptamers for targeted therapy of cancer: a review on cellular perspective.

Vandghanooni S, Eskandani M, Barar J, Omidi Y.

J Mol Med (Berl). 2018 Sep;96(9):885-902. doi: 10.1007/s00109-018-1669-y. Epub 2018 Jul 28. Review.

PMID:
30056527
15.

Mucin-1 aptamer-armed superparamagnetic iron oxide nanoparticles for targeted delivery of doxorubicin to breast cancer cells.

Aghanejad A, Babamiri H, Adibkia K, Barar J, Omidi Y.

Bioimpacts. 2018;8(2):117-127. doi: 10.15171/bi.2018.14. Epub 2018 May 5.

16.

Phage display selection of fully human antibody fragments to inhibit growth-promoting effects of glycine-extended gastrin 17 on human colorectal cancer cells.

Khajeh S, Tohidkia MR, Aghanejad A, Mehdipour T, Fathi F, Omidi Y.

Artif Cells Nanomed Biotechnol. 2018;46(sup2):1082-1090. doi: 10.1080/21691401.2018.1478846. Epub 2018 Jun 9.

PMID:
29886758
17.

Phage display-derived antibody fragments against conserved regions of VacA toxin of Helicobacter pylori.

Fahimi F, Sarhaddi S, Fouladi M, Samadi N, Sadeghi J, Golchin A, Tohidkia MR, Barar J, Omidi Y.

Appl Microbiol Biotechnol. 2018 Aug;102(16):6899-6913. doi: 10.1007/s00253-018-9068-4. Epub 2018 Jun 3.

PMID:
29862446
18.

Chitosan-based multifunctional nanomedicines and theranostics for targeted therapy of cancer.

Fathi M, Majidi S, Zangabad PS, Barar J, Erfan-Niya H, Omidi Y.

Med Res Rev. 2018 Sep;38(6):2110-2136. doi: 10.1002/med.21506. Epub 2018 May 30. Review.

PMID:
29846948
19.

Type 1 diabetes: Through the lens of human genome and metagenome interplay.

Zununi Vahed S, Moghaddas Sani H, Rahbar Saadat Y, Barzegari A, Omidi Y.

Biomed Pharmacother. 2018 Aug;104:332-342. doi: 10.1016/j.biopha.2018.05.052. Epub 2018 May 15. Review.

PMID:
29775902
20.

Combating atherosclerosis with targeted nanomedicines: recent advances and future prospective.

Nakhlband A, Eskandani M, Omidi Y, Saeedi N, Ghaffari S, Barar J, Garjani A.

Bioimpacts. 2018;8(1):59-75. doi: 10.15171/bi.2018.08. Epub 2018 Feb 25. Review.

Supplemental Content

Support Center